In human cancers, autophagy was first thought to be an anti‐tumorigenic process with ATG6/BECN1 haploinsufficiency detected in approximately 45 to 70% of breast, ovarian and prostate cancers (White, 2015). This evidence concerns the gene BECN1 and prostate carcinoma.